Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1988-7-11
pubmed:abstractText
Gentamicin was administered to six cats at a dosage of 3 mg/kg of body weight intravenously every 8 h for five days. Peak and trough serum gentamicin concentrations were measured after each injection. Gentamicin elimination rate and serum half-life were calculated. Serum urea nitrogen, creatinine, biochemistry profile, electrolyte, glucose, total protein, and albumin concentrations were measured daily. Urinalyses were performed before and after the five-day experimental period. The mean +/- SD peak serum gentamicin concentration was 7.19 +/- 1.10 micrograms/mL, and the trough concentration was 0.59 +/- 0.09 microgram/mL. These concentrations are known to be effective against most gentamicin-sensitive bacteria. The mean +/- SD gentamicin elimination rate was 0.0065 +/- 0.0004 min-1. The harmonic mean +/- pseudo standard deviation serum half-life of gentamicin was 107.21 +/- 12.79 min. There were no significant increases (P greater than 0.05) in clinicopathological variables. Microscopic examination of renal sections did not disclose pathological lesions. Signs of vestibular impairment were not observed. A dosage of 3 mg gentamicin/kg given intravenously every 8 h for five days was determined to be safe and to produce therapeutic blood levels in cats.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-1164007, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-14274880, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-335208, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-3354963, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-3709080, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-3761424, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-3771340, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-3975915, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-3989700, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-4094028, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-4497669, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-465287, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-4959982, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-512417, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-5305936, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-5305937, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-5788733, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-6479502, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-6642102, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-696753, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-7075115, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-7233490, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-808583, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-837654, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-900916, http://linkedlifedata.com/resource/pubmed/commentcorrection/3370552-942138
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0830-9000
pubmed:author
pubmed:issnType
Print
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
177-80
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Pharmacokinetic and pathological evaluation of gentamicin in cats given a small intravenous dose repeatedly for five days.
pubmed:affiliation
Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens 30602.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't